MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Spontaneous smoking cessation in a parkinsonian patient treated with apomorphine pump

    M. Auffret, C. Geny, A. Lees, M. Vérin (Rennes, France)

    Objective: To describe the case of a parkinsonian patient treated by apomorphine pump who stopped smoking without difficulty despite being dependent to nicotine. To explore…
  • MDS Virtual Congress 2020

    Efficacy and Safety of Opicapone in Parkinson’s Disease Patients According to Duration of Motor Fluctuations: Post-Hoc Analysis of BIPARK-I and II

    G. Ebersbach, O. Rascol, J. Ferreira, R. Costa, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Beelitz, Germany)

    Objective: This exploratory post-hoc analysis evaluated the efficacy and safety of opicapone (OPC) in levodopa-treated Parkinson’s disease (PD) patients with duration of motor fluctuations of…
  • MDS Virtual Congress 2020

    Monitoring electrophysiological recordings in patients with LCIJ therapy

    D. Gunal, H. Ozden, S. Irmak, K. Uluc (Istanbul, Turkey)

    Objective: Levodopa carbidopa intestinal jel (LCIJ) treatment for advanced Parkinson’s disease patients is live-saving for the appropriate patients, however follow up of the patients has…
  • MDS Virtual Congress 2020

    Correlation Between Dyskinesia and Quality of Life at Baseline and After 12 months of Treatment with LCIG in Patients with Advanced Parkinson’s Disease

    J. L Aldred, F. E Pontieri, L. Bergmann, T. Gao, P. Kukreja, P. Bourgeois, N. Kovács (Spokane, WA, USA)

    Objective: Evaluate the correlation between dyskinesia and quality of life (QoL) at baseline and after 12 months of treatment with levodopa-carbidopa intestinal gel (LCIG) in…
  • MDS Virtual Congress 2020

    New compound increasing glucocerebrosidase activity on primary cell cultures obtained from patients with GBA-associated Parkinson’s disease

    M. Nikolaev, A. Kopytova, K. Senkevich, G. Baydakova, I. Miliukhina, E. Zakharova, G. Rychkov, A. Cheblokov, F. Ibatullin, S. Pchelina, A. Emelyanov (Gatchina, Russian Federation)

    Objective: To determine whether new chemical modifications of the previously described allosteric GCase chaperone N607 (Aflaki E et.al Neurosc. 2016) increase GCase activity in monocyte-derived…
  • MDS Virtual Congress 2020

    High levodopa plasma concentration in the acute levodopa challenge test predicts levodopa-induced dyskinesia in Parkinson’s disease

    T. Shiraishi, N. Nishikawa, Y. Mukai, Y. Takahashi (Kodaira-shi, Tokyo, Japan)

    Objective: We aimed to investigate the correlation between levodopa pharmacokinetics and levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD). Background: In patients with PD, pulsatile dopaminergic…
  • MDS Virtual Congress 2020

    Sensor-Based Gait Measurements Predict Subthalamic Deep Brain Stimulation Frequency in Parkinson’s Disease Patients – A Proof of Concept Study

    J. Watts, A. Khojandi, O. Shylo, R. Ramdhani (Knoxville, TN, USA)

    Objective: To conduct a proof-of-concept study to demonstrate that objectively measured gait kinematics can predict the choice of subthalamic nucleus deep brain stimulation (STN-DBS) frequency…
  • MDS Virtual Congress 2020

    Electrochemical skin conductance as a marker of autonomic failure in patients with Multiple System Atrophy

    S. Perez-Lloret, V. Fabry, F. Ory-Magne, C. Brefel-Courbon, A. Foubert-Samier, W. Meissner, O. Rascol, J. Senard, A. Pavy-Le Traon (Toulouse, France)

    Objective: We investigated the interest of a quick and non-invasive assessment of sweating as a marker of autonomic failure (AF) in Multiple System Atrohpy (MSA).…
  • MDS Virtual Congress 2020

    Midbrain/pons area ratio and clinical features predict the prognosis of Progressive Supranuclear Palsy

    S-S. Cui, Y-Y. Tan, S.D Chen (Shanghai, China)

    Objective: This retrospective study aims to characterize the natural history of PSP and to find predictors of shorter survival and faster decline of activity of…
  • MDS Virtual Congress 2020

    Vascular Parkinsonism (VP) score: A clinical scoring system to differentiate between vascular from degenerative parkinsonism

    M.I Acharya (Kolkata, India)

    Objective: To establish a clinical scoring system to differentiate between vascualar from degenerative parkinsonism. Background: Vascular parkinsonism (VP) constitutes (5-8) % of all parkinsonian disorders.…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley